Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Farrell

Showing results (481-490 of 522) with videos related to

Pageof 53
Sort By:
Addiction (Abingdon, England)|December 19, 2024
Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trialNadine Ezard, Brendan Clifford, Krista J Siefried, et al.
Drug and Alcohol Review|February 11, 2025
A mixed-methods study of staff perspectives on the barriers and facilitators to the implementation of patient-reported routine outcome measures and feedback in alcohol and other drug treatmentNina Pocuca, Gabrielle Campbell, Anthony Barnett, et al.
The Lancet. Global Health|March 30, 2023
Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic reviewLouisa Degenhardt, Paige Webb, Samantha Colledge-Frisby, et al.
Trials|September 14, 2022
Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trialBridget C Howard, Hayden McRobbie, Dennis Petrie, et al.
Journal of Bacteriology|July 27, 2002
From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathwaysSvetlana Y Gerdes, Michael D Scholle, Mark D'Souza, et al.
Trials|January 28, 2026
The effectiveness of a motivational interviewing-based intervention for reducing depressive symptoms after stroke compared to an attention control and usual care: study protocol for a multi-centre randomised controlled trial (COMMITS)Kulsum Patel, Caroline Watkins, Valerio Benedetto, et al.
The Lancet. Public Health|November 4, 2024
The Lancet Public Health Commission on gamblingHeather Wardle, Louisa Degenhardt, Virve Marionneau, et al.
Addiction (Abingdon, England)|December 28, 2018
The effectiveness, safety and cost-effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non-inferiority trialDennis Thomas, Michael Farrell, Hayden McRobbie, et al.
Vox Sanguinis|October 5, 2023
Current state of technical transfusion medicine practice for out-of-hospital blood transfusion in CanadaIsabelle Blais-Normandin, Tihiro Rymer, Shelley Feenstra, et al.
American Journal of Human Genetics|May 10, 2011
Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in CLN6Todor Arsov, Katherine R Smith, John Damiano, et al.
Pageof 53

Showing results (481-490 of 522) with videos related to

Sort By:
Pageof 53
Addiction (Abingdon, England)|December 19, 2024
Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trialNadine Ezard, Brendan Clifford, Krista J Siefried, et al.
Drug and Alcohol Review|February 11, 2025
A mixed-methods study of staff perspectives on the barriers and facilitators to the implementation of patient-reported routine outcome measures and feedback in alcohol and other drug treatmentNina Pocuca, Gabrielle Campbell, Anthony Barnett, et al.
The Lancet. Global Health|March 30, 2023
Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic reviewLouisa Degenhardt, Paige Webb, Samantha Colledge-Frisby, et al.
Trials|September 14, 2022
Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trialBridget C Howard, Hayden McRobbie, Dennis Petrie, et al.
Journal of Bacteriology|July 27, 2002
From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathwaysSvetlana Y Gerdes, Michael D Scholle, Mark D'Souza, et al.
Trials|January 28, 2026
The effectiveness of a motivational interviewing-based intervention for reducing depressive symptoms after stroke compared to an attention control and usual care: study protocol for a multi-centre randomised controlled trial (COMMITS)Kulsum Patel, Caroline Watkins, Valerio Benedetto, et al.
The Lancet. Public Health|November 4, 2024
The Lancet Public Health Commission on gamblingHeather Wardle, Louisa Degenhardt, Virve Marionneau, et al.
Addiction (Abingdon, England)|December 28, 2018
The effectiveness, safety and cost-effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non-inferiority trialDennis Thomas, Michael Farrell, Hayden McRobbie, et al.
Vox Sanguinis|October 5, 2023
Current state of technical transfusion medicine practice for out-of-hospital blood transfusion in CanadaIsabelle Blais-Normandin, Tihiro Rymer, Shelley Feenstra, et al.
American Journal of Human Genetics|May 10, 2011
Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in CLN6Todor Arsov, Katherine R Smith, John Damiano, et al.
Pageof 53